Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Pulmonology

  • News

    Ruling out PE in patients with low C-PTP and D dimer of less than 1,000 ng/mL

    April 30, 2021

    Can we rule out pulmonary embolism (PE) in patients with a low clinical pretest probability (C-PTP) and a D dimer of less than 1,000 ng/mL?

  • 1
    News

    Pediatric bronchiolitis: Less is more

    April 27, 2021

    With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on supportive care, researchers say.

  • 1
    News

    Pneumonia risk soars in heart failure patients, especially HFpEF

    April 19, 2021

    An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular events.

  • News

    How some COVID-19 vaccines could cause rare blood clots

    April 14, 2021

    Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.

  • 1
    News

    List of COVID-19 high-risk comorbidities expanded

    April 6, 2021

    Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.

  • News

    New guidelines on antibiotic prescribing focus on shorter courses

    April 6, 2021

    “Many physicians do not prescribe short-course therapy, frequently defaulting to 10-day courses regardless of the condition.”

  • News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

  • 1
    News

    New guidelines on the diagnosis and treatment of adults with CAP

    March 30, 2021

    What are the most up-to-date, evidence-based recommendations for the diagnosis and treatment of community-acquired pneumonia (CAP)?

  • News

    Pediatric bronchiolitis admissions to ICU fall during COVID-19

    March 29, 2021

    It’s unlikely that the reduction in bronchiolitis PICU admissions was due to parents not bringing babies to the hospital or infants not getting admitted.

  • 1
    News

    Metoprolol increases severity, but not risk, of COPD exacerbations

    March 26, 2021

    Does metoprolol affect time until exacerbation in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without an alternative indication for beta-blocker use?

Previous1 … 7 8 9 10 11 … 60Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences